Trials / Completed
CompletedNCT02751450
The Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity(DH)
A Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 263 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This single centre, comparative design study will be used to investigate the efficacy of an experimental stannous fluoride containing dentifrice in relieving dentinal hypersensitivity (DH) after short term use compared with a standard fluoride dentifrice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Stannous Fluoride dentifice | Experimental dentifrice containing 0.454% w/w stannous fluoride (1100ppm) |
| OTHER | Sodium Monofluorophosphate dentifrice | Dentifrice containing 0.76% sodium monofluorophosphate (1000ppm fluoride) |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2016-05-01
- Completion
- 2016-06-17
- First posted
- 2016-04-26
- Last updated
- 2017-05-17
- Results posted
- 2017-03-07
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02751450. Inclusion in this directory is not an endorsement.